Emcure Pharma Listing: Namita Thapar made huge profit!!!
Emcure Pharma Listing: Namita Thapar made huge profit!!!Shares of Emcure Pharma, a company invested by Namita Thapar, the judge of Shark Tank india and full-time director of Emcure Pharma, had a strong listing in the stock market today. On Wednesday, the company's shares were listed on NSE and BSE with a premium of 31.45 percent. The company's shares have given Namita Thapar bumper profits along with the listing. In fact, in this IPO, Namita Thapar has sold more than 12 lakh shares in the pharma company through Offer for Sale. With the help of Emcure's great listing, Namita Thapar has earned very well.Namita Thapar made a profit of more than Rs 120 croreNamita Thapar, who is part of the promoter group of Emcure Pharma, has earned more than Rs 120 crore through the listing of this IPO. According to the report of Economic Times, Namita Thapar had more than 63 lakh shares of the company till march 2024. She had bought these shares at a price of just Rs 3.44 per share. In such a situation, she had invested Rs 2.19 crore in the company in the initial phase. In this IPO, she has sold 12.68 lakh equity shares. In such a situation, Namita Thapar would have earned Rs 127.87 crore by listing the shares at a 31 percent premium to the price band.The value of the remaining shares increased to this muchAfter the listing of Emcure shares, the value of the remaining 50.71 lakh equity shares with Namita Thapar has increased by 38,200 percent and has reached around Rs 671 crore.